PETMED EXPRESS, INC. Excess Tax Benefit from Share-based Compensation, Financing Activities
PETMED EXPRESS, INC. (PETS) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $115.00 thousand for the 9-month period ending 2016-12-31, per its 10-Q filed 2018-01-30.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2018-05-29
- PETMED EXPRESS, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-12-31 was $0.00.
- PETMED EXPRESS, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was $50.00K, a 163.16% increase year-over-year.
- PETMED EXPRESS, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-12-31 was $0.00.
- PETMED EXPRESS, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-03-31 was $19.00K.
- PETMED EXPRESS, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $142.00K, a 144.83% increase from fiscal 2015.
- PETMED EXPRESS, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $58.00K, a 41.41% decline from fiscal 2014.
- PETMED EXPRESS, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $99.00K.
- PETMED EXPRESS, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2013 was -$284.00K.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-01-30 | $115.00K 10-Q · filed 2018-01-30 | ||
| 2016-09-30 | $115.00K 10-Q · filed 2017-10-31 | |||
| 2016-03-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-29 | $50.00K derived: sum of 2 quarters · filed 2018-05-29 | $142.00K 10-K · filed 2018-05-29 | |
| 2015-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-02 | $92.00K 10-Q · filed 2016-02-02 | ||
| 2015-09-30 | $92.00K 10-Q · filed 2015-10-27 | |||
| 2015-03-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-23 | $19.00K derived: sum of 2 quarters · filed 2017-05-23 | $58.00K 10-K · filed 2017-05-23 | |
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-02 | $39.00K 10-Q · filed 2016-02-02 | ||
| 2014-09-30 | $39.00K 10-Q · filed 2015-10-27 | |||
| 2014-03-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-05-24 | $99.00K 10-K · filed 2016-05-24 | ||
| 2013-12-31 | $123.00K 10-Q · filed 2015-01-26 | |||
| 2013-03-31 | -$284.00K 10-K · filed 2015-05-22 | |||
| 2012-03-31 | -$240.00K 10-K · filed 2014-05-27 | |||
| 2010-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-01-31 | $0.00 derived: sum of 2 quarters · filed 2012-01-31 | $124.00K 10-Q · filed 2012-01-31 | |
| 2010-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-01 | $124.00K 10-Q · filed 2011-11-01 | ||
| 2010-06-30 | $124.00K 10-Q · filed 2011-08-02 | |||
| 2010-03-31 | $299.00K 10-K · filed 2012-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |